52923-39-4

Upstream product

• 104-88-1 4-chlorobenzaldehyde 
• 118-93-4 o-hydroxyacetophenone 
• 930-69-8 sodium thiophenolate 
• 67139-33-7 Methanesulfonic acid (2R,3R)-2-(4-chloro-phenyl)-4-oxo-chroman-3-yl ester 
• 1840-01-3 (E)-1-(2-hydroxyphenyl)-3-(4-fluorophenyl)prop-2-en-1-one 
• 88701-87-5 4-[(E)-2-(4-Chloro-phenyl)-vinyl]-benzo[e][1,2,3]oxathiazine 2,2-dioxide 
• 108-98-5 thiophenol 
• 71-23-8 propan-1-ol 
• 64-17-5 ethanol 
• 75-07-0 acetaldehyde 
• 122-79-2 Phenyl acetate 
• 5101-44-0 2-ethynyl-phenol 
• 19311-91-2 N,N-diethylsalicylamide 
• 65009-00-9 O-phenyl N,N-diethylcarbamate 

Downstream Products

• 80149-10-6 6-p-Chlorophenyl-6H-<1>benzopyrano<4,3-b><1,8>naphthyridine 
• 139006-32-9 (2S,3R)-2-(4-Chloro-phenyl)-4,4-dimethoxy-chroman-3-ol 
• 88701-87-5 4-[(E)-2-(4-Chloro-phenyl)-vinyl]-benzo[e][1,2,3]oxathiazine 2,2-dioxide 
• 88701-92-2 C₁₆H₁₁Cl₂NO₅S 
• 90834-26-7 4-[(E)-2-(4-Chloro-phenyl)-vinyl]-chromen-2-one 
• 65840-95-1 3-(2′-hydroxyphenyl)-5-(4-chlorophenyl)pyrazoline 
• 86691-08-9 5-(4'-chlorophenyl)-3-(2''-hydroxyphenyl)-1-phenyl-2-pyrazoline 
• 84634-56-0 2-[2-(4-chlorophenyl)-2,3-dihydro-1H-1,5-benzodiazepin-4-yl]phenol 
• 38216-61-4 Z-2-[(4-chlorophenyl)methylene]benzo[b]furan-3-one 
• 67139-36-0 3-amino-2-(4-chlorophenyl)-4H-1-benzopyran-4-one 
• 92830-90-5 (Z)-α-azido-2'-chlorochalcone 
• 19743-21-6 5-(2-hydroxyphenyl)-3-(4-chloro-phenyl)-isoxazole 
• 73110-68-6 2-(4-chloro-phenyl)-chroman 
• 10420-75-4 4'-chloroflavone 

Relevant academic research and scientific papers

Convenient synthesis of flavanone derivatives via oxa-Michael addition using catalytic amount of aqueous cesium fluoride

A total of 36 flavanones, which included polycyclic aromatic and heterocyclic rings, were readily synthesized via oxa-Michael addition from the corresponding hydroxychalcones with a catalytic amount of aqueous cesium fluoride solution under mild conditions. This method could be applied to the scalable synthesis of eriodictyol as a known potent inhibitor of the SARS-CoV-2 spike protein.

Ruthenium organometallics of chloro-substituted 2′-hydroxychalcones – A story of catecholase biomimetics beyond copper

Four new organoruthenium(II) compounds of 2’-hydroxychalcones, differing in the position of the chloro substituent at chalcone moiety, were prepared by solution synthesis and characterized by chemical analysis, infrared and electron spectroscopy, mass spectrometry and 1D and 2D NMR spectroscopy, as biomimetic functional models of catechol oxidase. The molecular and crystal structures of three compounds were determined by single crystal X-ray diffraction. The organometallics are neutral species having piano-stool pseudo octahedral geometry with ruthenium(II) coordinated by η6-cymene, bidentate monobasic 2’-hydroxychalcone ligand, and chloride ion. The catecholase activity of new organometallics was investigated by electron spectroscopy in three solvents at three temperatures. The kinetic measurements were done under pseudo first order conditions and vmax, kcat, KM, TON, TOF, and Ea values are determined. Compounds (1) – (4) have solvent-dependent catecholase activity with activity decreasing in order ethanol > methanol ? acetonitrile. The highest kcat value and the lowest activation energy were found for the reaction catalyzed by organometallic (4), having a chloro substituent at the B ring of the chalcone ligand in the para position. The kcat values of 104 h?1 and 105 h?1 order at 297 K and 307 K, respectively classify these organometallics among the best artificial functional models of catechol oxidase. The results indicate that the catechol oxidation mediated by organometallics (1) – (4) proceeds via semiquinone radical formation.

Multitarget 2′-hydroxychalcones as potential drugs for the treatment of neurodegenerative disorders and their comorbidities

The complex nature of neurodegenerative diseases (NDDs), such as Alzheimer's disease (AD) and Parkinson's disease (PD) calls for multidirectional treatment. Restoring neurotransmitter levels by combined inhibition of cholinesterases (ChEs) and monoamine oxidases (MAOs, MAO-A and MAO-B), in conjunction with strategies to counteract amyloid β (Aβ) aggregation, may constitute a therapeutically strong multi-target approach for the treatment of NDDs. Chalcones are a subgroup of flavonoids with a broad spectrum of biological activity. We report here the synthesis of 2′-hydroxychalcones as MAO-A and MAO-B inhibitors. Compounds 5c (IC50 = 0.031 ± 0.001 μM), 5a (IC50 = 0.084 ± 0.003 μM), 2c (IC50 = 0.095 ± 0.019 μM) and 2a (IC50 = 0.111 ± 0.006 μM) were the most potent, selective and reversible inhibitors of human (h)MAO-B isoform. hMAO-B inhibitors 1a, 2a and 5a also inhibited murine MAO-B in vivo in mouse brain homogenates. Molecular modelling rationalised the binding mode of 2′-hydroxychalcones in the active site of hMAO-B. Additionally, several derivatives inhibited murine acetylcholinesterase (mAChE) (IC50 values from 4.37 ± 0.83 μM to 15.17 ± 6.03 μM) and reduced the aggregation propensity of Aβ. Moreover, some derivatives bound to the benzodiazepine binding site (BDZ-bs) of the γ-aminobutyric acid A (GABAA) receptors (1a and 2a with Ki = 4.9 ± 1.1 μM and 5.0 ± 1.1 μM, respectively), and exerted sedative and/or anxiolytic like effects on mice. The biological results reported here on 2′-hydroxychalcones provide an extension to previous studies on chalcone scaffold and show them as a potential treatment strategy for NDDs and their associated comorbidities.

Spectroscopic analysis by NMR, FT-Raman, ATR-FTIR, and UV-Vis, evaluation of antimicrobial activity, and in silico studies of chalcones derived from 2-hydroxyacetophenone

Six 2’-hydroxychalcones were synthesized and characterized by NMR, FT-Raman, ATR-FTIR, and UV-Vis. These chalcones alone and in combination with the ciprofloxacin, penicillin, and erythromycin antibiotics were tested against multiresistant strains of Staphylococcus aureus. It was also verified by in vitro and in silico studeis the capacity of these chalcones to inhibit the NorA efflux pump. The MICs values of ciprofloxacin were reduced in the presence of all tested chalcones. For norfloxacin antibiotic, the chalcones A1, A4, A5 and A6 promoted the reduced in the MIC values. The A2 chalcone was the only one to reduce the MIC values when associated with penicillin. Any chalcones were not able to reduce MIC values when associated with erythromycin. These results indicate that the synergistic effects demonstrated for the synthesized chalcones were influenced by the introduction of a furanic ring (A1), a chlorine atom and a methoxy group at the C4 position (A2 and A4), a second double bond (A5), and a fluorine atom at the C2 position (A6). The ADMET analysis predicts that the chalcones A2, A3, A5 and A6 have easier cell permeation. The nucleophilic region makes the A5 chalcone capable of covalently bonding with plasma proteins, and the presence of oxygenated aromatic substitutions makes the chalcones A1 and A4 more water-soluble and consequently easier to excrete. On the other hand, the substitution of the methoxy group of the A4 chalcone makes it more susceptible to O-demethylation reactions by the CYP3A4 isoenzyme. The molecular docking revealed that all six chalcones could hinder the binding of norfloxacin to the NorA efflux pump.

Microwave assisted synthesis, characterization, molecular docking and pharmacological activities of some new 2′-hydroxychalcone derivatives

Synthesis of six new α, β-unsaturated carbonyl compounds (2′-hydroxychalcones) from 2′-hydroxyacethophenone and aromatic aldehyde derivatives under microwave condition has been described due to their pharmaceutical interest. They were characterized by FTI

Not only AIE: Light-sensitivity of 4-dimethylamino-2′-hydroxychalcones beneficial to highly efficient photochemical synthesis of 4′-dimethylaminoflavanones

4-dimethylamino-2′-hydroxychalcone in crystals is well known for its aggregation induced emission (AIE) in the red region of spectrum. We however observe that in liquid solutions this dye and its analogues undergo reversible wavelength-dependent light-induced cyclization to the flavanone derivatives. Special care thus should be taken when this compound is used for optoelectronic applications requiring high purity, especially via solution-processed methods. The discussed intramolecular cyclization proceeds faster in nonpolar medium and is quenched completely in the presence of protic solvents or via formation of aggregates in crystal phase. In spite of that quantum yield of a single photoinduced transformation does not exceed 1%, continuous irradiation affords 92% of product which makes it the most efficient preparation route for 4′-dimethylminoflavanone and its derivatives among the ones reported before. According to the DFT and TDDFT calculations supported by the experimentally investigated spectral features, the mechanism of photoinduced formation of a 4′-dimethylaminoflavanone involves several transformations: excited state intramolecular proton transfer (ESIPT), excited and ground state rotational isomerization from s-trans to s-cis isomer, cyclization and enol-keto tautomerization via proton transfer in the ground state.

COMPOSITION FOR PROTECTING KIDNEY CONTAINING CHALCONE DERIVATIVES

The present invention relates to a composition for protecting a kidney or a composition for alleviating kidney diseases which contains a chalcone derivative. When the compound according to the present invention is used, the kidney can be protected from nephrotoxicity due to drugs and the like. Therefore, by utilizing the present specification, it is possible to make a great contribution to fields of patient treatment and welfare.COPYRIGHT KIPO 2019

Halo-substituted chalcones and azachalcones-inhibited, lipopolysaccharited-stimulated, pro-inflammatory responses through the TLR4-mediated pathway

A series of B-ring, halo-substituted chalcones and azachalcones were synthesized to evaluate and compare their anti-inflammatory activity. Mouse BALB/c macrophage RAW 264.7 were pre-treated with 10 μg/mL of each compound for one hour before induction of i

From Carbamate to Chalcone: Consecutive Anionic Fries Rearrangement, Anionic Si → C Alkyl Rearrangement, and Claisen-Schmidt Condensation

A highly efficient one-pot procedure was developed for the synthesis of various 2′-hydroxychalcones from phenyl diethylcarbamate, featuring consecutive Snieckus-Fries rearrangement, anionic Si a?' C alkyl rearrangement, and Claisen-Schmidt condensation in a single operation. The applicability of this protocol was demonstrated by the highly efficient synthesis of the anti-inflammatory natural product lonchocarpin. The mechanism insight is also provided.

Synthesis of 5-subsituted flavonols via the Algar-Flynn-Oyamada (AFO) reaction: The mechanistic implication

Herein, we report a synthetic method with improved selectivity for 5-substituted flavonols via the Algar-Flynn-Oyamada reaction (AFO), by using of sodium carbonate/hydrogen peroxide A series of 5-substituted flavonols was obtained with moderate to high yields. The mechanism of the AFO reaction was elucidated. LCMS analysis and in situ 1H NMR analysis indicated that the epoxide was involved in the transformation from chalcone to flavonol and/or aurone under alkaline base/peroxide conditions.